Safe and effective use of nivolumab for treating lung adenocarcinoma associated with sporadic lymphangioleiomyomatosis: a rare case report View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-12

AUTHORS

Johan Pluvy, Solenn Brosseau, Sandrine Stelianides, Claire Danel, Marina Nguenang, Antoine Khalil, Bruno Crestani, Gérard Zalcman, Valérie Gounant

ABSTRACT

BACKGROUND: Sporadic lymphangioleiomyomatosis (LAM) is a rare form of diffuse parenchymal lung disease. PD-1 blocking antibodies constitute an essential treatment option for advanced non-small-cell lung cancer (NSCLC). The effect of immune checkpoint inhibitors in lymphangioleiomyomatosis patients with non-small cell lung cancer is unknown: concomitant symptomatic interstitial lung disease or the use of immunosuppressors was a key exclusion criterion in the original studies of immune checkpoint inhibitors, especially regarding the risk of interstitial lung disease exacerbation. CASE PRESENTATION: A 48-year-old female, active smoker (36 pack-years), diagnosed with sporadic LAM since 2004 suffered from metastatic adenocarcinoma of the lung. Third-line therapy with nivolumab was started in 2015, with a major partial response. Due to pulmonary function alterations, sirolimus was also reinitiated in 2017 in conjunction with nivolumab, without any undesirable effects and a major partial response continuing up to May 2018. CONCLUSIONS: This case highlights the safe and effective use of nivolumab for managing metastatic lung adenocarcinoma that occurred in a patient with sporadic LAM. In the current case, immunotherapy proved highly successful in managing the NSCLC tumor that occurred upon LAM follow-up, with both a significantly prolonged partial response and acceptable safety profile. More... »

PAGES

12

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12890-018-0775-5

DOI

http://dx.doi.org/10.1186/s12890-018-0775-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1111363363

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30634951


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "H\u00f4pital Bichat-Claude-Bernard", 
          "id": "https://www.grid.ac/institutes/grid.411119.d", 
          "name": [
            "Service d\u2019Oncologie Thoracique, H\u00f4pital Bichat, 46 rue Henri Huchard, 75018, Paris, France", 
            "CIC INSERM 1425-CLIP2 Paris-Nord, H\u00f4pital Bichat-Claude Bernard, 46 rue Henri Huchard 75018, AP-HP, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pluvy", 
        "givenName": "Johan", 
        "id": "sg:person.013444441273.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013444441273.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "H\u00f4pital Bichat-Claude-Bernard", 
          "id": "https://www.grid.ac/institutes/grid.411119.d", 
          "name": [
            "Service d\u2019Oncologie Thoracique, H\u00f4pital Bichat, 46 rue Henri Huchard, 75018, Paris, France", 
            "CIC INSERM 1425-CLIP2 Paris-Nord, H\u00f4pital Bichat-Claude Bernard, 46 rue Henri Huchard 75018, AP-HP, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brosseau", 
        "givenName": "Solenn", 
        "id": "sg:person.01061777002.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01061777002.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "H\u00f4pital Bichat-Claude-Bernard", 
          "id": "https://www.grid.ac/institutes/grid.411119.d", 
          "name": [
            "Service de R\u00e9habilitation Respiratoire, H\u00f4pital Bichat, 46 rue Henri Huchard, 75018, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stelianides", 
        "givenName": "Sandrine", 
        "id": "sg:person.013315250654.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013315250654.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "H\u00f4pital Bichat-Claude-Bernard", 
          "id": "https://www.grid.ac/institutes/grid.411119.d", 
          "name": [
            "Service d\u2019Anatomie Pathologique, H\u00f4pital Bichat, 46 rue Henri Huchard, 75018, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Danel", 
        "givenName": "Claire", 
        "id": "sg:person.01265670501.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265670501.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "H\u00f4pital Bichat-Claude-Bernard", 
          "id": "https://www.grid.ac/institutes/grid.411119.d", 
          "name": [
            "Service d\u2019Oncologie Thoracique, H\u00f4pital Bichat, 46 rue Henri Huchard, 75018, Paris, France", 
            "CIC INSERM 1425-CLIP2 Paris-Nord, H\u00f4pital Bichat-Claude Bernard, 46 rue Henri Huchard 75018, AP-HP, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nguenang", 
        "givenName": "Marina", 
        "id": "sg:person.014312260733.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014312260733.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "H\u00f4pital Bichat-Claude-Bernard", 
          "id": "https://www.grid.ac/institutes/grid.411119.d", 
          "name": [
            "Service de Radiologie, H\u00f4pital Bichat, 46 rue Henri Huchard, 75018, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Khalil", 
        "givenName": "Antoine", 
        "id": "sg:person.01143547471.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143547471.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "H\u00f4pital Bichat-Claude-Bernard", 
          "id": "https://www.grid.ac/institutes/grid.411119.d", 
          "name": [
            "Service de Pneumologie, H\u00f4pital Bichat, 46 rue Henri Huchard, 75018, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Crestani", 
        "givenName": "Bruno", 
        "id": "sg:person.0671403157.95", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0671403157.95"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "H\u00f4pital Bichat-Claude-Bernard", 
          "id": "https://www.grid.ac/institutes/grid.411119.d", 
          "name": [
            "Service d\u2019Oncologie Thoracique, H\u00f4pital Bichat, 46 rue Henri Huchard, 75018, Paris, France", 
            "CIC INSERM 1425-CLIP2 Paris-Nord, H\u00f4pital Bichat-Claude Bernard, 46 rue Henri Huchard 75018, AP-HP, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zalcman", 
        "givenName": "G\u00e9rard", 
        "id": "sg:person.01371171317.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01371171317.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "H\u00f4pital Bichat-Claude-Bernard", 
          "id": "https://www.grid.ac/institutes/grid.411119.d", 
          "name": [
            "Service d\u2019Oncologie Thoracique, H\u00f4pital Bichat, 46 rue Henri Huchard, 75018, Paris, France", 
            "CIC INSERM 1425-CLIP2 Paris-Nord, H\u00f4pital Bichat-Claude Bernard, 46 rue Henri Huchard 75018, AP-HP, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gounant", 
        "givenName": "Val\u00e9rie", 
        "id": "sg:person.0742436717.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0742436717.71"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1056/nejmoa1507643", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000663586"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1100391", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002019704"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2353/ajpath.2009.090900", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011644532"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3322/caac.21262", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013257560"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1164/rccm.200409-1298oc", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018349460"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1164/rccm.200409-1298oc", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018349460"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1183/13993003.00412-2015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022541062"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1183/13993003.00412-2015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022541062"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1183/13993003.00412-2015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022541062"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2147/clep.s50780", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026267450"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1164/rccm.201308-1483st", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032608484"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1378/chest.07-0898", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033754583"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1606774", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037631694"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2353/ajpath.2009.090525", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045545118"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.anndiagpath.2015.06.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048936505"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1504627", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052572745"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmra1703481", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100292997"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1165/rcmb.2018-0123oc", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106103078"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1165/rcmb.2018-0123oc", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106103078"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-12", 
    "datePublishedReg": "2019-12-01", 
    "description": "BACKGROUND: Sporadic lymphangioleiomyomatosis (LAM) is a rare form of diffuse parenchymal lung disease. PD-1 blocking antibodies constitute an essential treatment option for advanced non-small-cell lung cancer (NSCLC). The effect of immune checkpoint inhibitors in lymphangioleiomyomatosis patients with non-small cell lung cancer is unknown: concomitant symptomatic interstitial lung disease or the use of immunosuppressors was a key exclusion criterion in the original studies of immune checkpoint inhibitors, especially regarding the risk of interstitial lung disease exacerbation.\nCASE PRESENTATION: A 48-year-old female, active smoker (36 pack-years), diagnosed with sporadic LAM since 2004 suffered from metastatic adenocarcinoma of the lung. Third-line therapy with nivolumab was started in 2015, with a major partial response. Due to pulmonary function alterations, sirolimus was also reinitiated in 2017 in conjunction with nivolumab, without any undesirable effects and a major partial response continuing up to May 2018.\nCONCLUSIONS: This case highlights the safe and effective use of nivolumab for managing metastatic lung adenocarcinoma that occurred in a patient with sporadic LAM. In the current case, immunotherapy proved highly successful in managing the NSCLC tumor that occurred upon LAM follow-up, with both a significantly prolonged partial response and acceptable safety profile.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12890-018-0775-5", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024955", 
        "issn": [
          "1471-2466"
        ], 
        "name": "BMC Pulmonary Medicine", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "19"
      }
    ], 
    "name": "Safe and effective use of nivolumab for treating lung adenocarcinoma associated with sporadic lymphangioleiomyomatosis: a rare case report", 
    "pagination": "12", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "34494ee5f9e8fe2b4a53879375ccfa0d21715d3ffc510d30bb52ceecb5ed433e"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30634951"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100968563"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12890-018-0775-5"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1111363363"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12890-018-0775-5", 
      "https://app.dimensions.ai/details/publication/pub.1111363363"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T08:41", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000320_0000000320/records_101387_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs12890-018-0775-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12890-018-0775-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12890-018-0775-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12890-018-0775-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12890-018-0775-5'


 

This table displays all metadata directly associated to this object as RDF triples.

174 TRIPLES      21 PREDICATES      44 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12890-018-0775-5 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N08e4c5afec8140308c3919873f87d9f8
4 schema:citation https://doi.org/10.1016/j.anndiagpath.2015.06.003
5 https://doi.org/10.1056/nejmoa1100391
6 https://doi.org/10.1056/nejmoa1504627
7 https://doi.org/10.1056/nejmoa1507643
8 https://doi.org/10.1056/nejmoa1606774
9 https://doi.org/10.1056/nejmra1703481
10 https://doi.org/10.1164/rccm.200409-1298oc
11 https://doi.org/10.1164/rccm.201308-1483st
12 https://doi.org/10.1165/rcmb.2018-0123oc
13 https://doi.org/10.1183/13993003.00412-2015
14 https://doi.org/10.1378/chest.07-0898
15 https://doi.org/10.2147/clep.s50780
16 https://doi.org/10.2353/ajpath.2009.090525
17 https://doi.org/10.2353/ajpath.2009.090900
18 https://doi.org/10.3322/caac.21262
19 schema:datePublished 2019-12
20 schema:datePublishedReg 2019-12-01
21 schema:description BACKGROUND: Sporadic lymphangioleiomyomatosis (LAM) is a rare form of diffuse parenchymal lung disease. PD-1 blocking antibodies constitute an essential treatment option for advanced non-small-cell lung cancer (NSCLC). The effect of immune checkpoint inhibitors in lymphangioleiomyomatosis patients with non-small cell lung cancer is unknown: concomitant symptomatic interstitial lung disease or the use of immunosuppressors was a key exclusion criterion in the original studies of immune checkpoint inhibitors, especially regarding the risk of interstitial lung disease exacerbation. CASE PRESENTATION: A 48-year-old female, active smoker (36 pack-years), diagnosed with sporadic LAM since 2004 suffered from metastatic adenocarcinoma of the lung. Third-line therapy with nivolumab was started in 2015, with a major partial response. Due to pulmonary function alterations, sirolimus was also reinitiated in 2017 in conjunction with nivolumab, without any undesirable effects and a major partial response continuing up to May 2018. CONCLUSIONS: This case highlights the safe and effective use of nivolumab for managing metastatic lung adenocarcinoma that occurred in a patient with sporadic LAM. In the current case, immunotherapy proved highly successful in managing the NSCLC tumor that occurred upon LAM follow-up, with both a significantly prolonged partial response and acceptable safety profile.
22 schema:genre research_article
23 schema:inLanguage en
24 schema:isAccessibleForFree true
25 schema:isPartOf N2c6d77ee305d40c28c5447b5ef14a716
26 Nb2ceda71cb684b32bf376518ceafce8c
27 sg:journal.1024955
28 schema:name Safe and effective use of nivolumab for treating lung adenocarcinoma associated with sporadic lymphangioleiomyomatosis: a rare case report
29 schema:pagination 12
30 schema:productId N1c0d0f2217ad42b985ecc4b13104ec82
31 N7745492d4b5a4de5ae5a4375808bdf4f
32 N7b350da759aa44269a0bd88cdb8358ae
33 Na92b4fc42f714a6c98faf7bcb6aabab4
34 Nbb4cb516c9854948905db0b755b66a9c
35 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111363363
36 https://doi.org/10.1186/s12890-018-0775-5
37 schema:sdDatePublished 2019-04-11T08:41
38 schema:sdLicense https://scigraph.springernature.com/explorer/license/
39 schema:sdPublisher Nc01d9eeb6aa745bab2d8ac45749ba0d6
40 schema:url https://link.springer.com/10.1186%2Fs12890-018-0775-5
41 sgo:license sg:explorer/license/
42 sgo:sdDataset articles
43 rdf:type schema:ScholarlyArticle
44 N08e4c5afec8140308c3919873f87d9f8 rdf:first sg:person.013444441273.04
45 rdf:rest N0fe085d636bd4d7992cd904cb66a5a9d
46 N0fe085d636bd4d7992cd904cb66a5a9d rdf:first sg:person.01061777002.04
47 rdf:rest Nbb33db3abbf448caa1c97464b00f5202
48 N157130a79d314fe295426b5fdf1c3155 rdf:first sg:person.01265670501.55
49 rdf:rest Ne1a37d88674048a3885e66d1943b9495
50 N1c0d0f2217ad42b985ecc4b13104ec82 schema:name dimensions_id
51 schema:value pub.1111363363
52 rdf:type schema:PropertyValue
53 N2c6d77ee305d40c28c5447b5ef14a716 schema:volumeNumber 19
54 rdf:type schema:PublicationVolume
55 N7745492d4b5a4de5ae5a4375808bdf4f schema:name nlm_unique_id
56 schema:value 100968563
57 rdf:type schema:PropertyValue
58 N7b350da759aa44269a0bd88cdb8358ae schema:name readcube_id
59 schema:value 34494ee5f9e8fe2b4a53879375ccfa0d21715d3ffc510d30bb52ceecb5ed433e
60 rdf:type schema:PropertyValue
61 Na92b4fc42f714a6c98faf7bcb6aabab4 schema:name pubmed_id
62 schema:value 30634951
63 rdf:type schema:PropertyValue
64 Nb2ceda71cb684b32bf376518ceafce8c schema:issueNumber 1
65 rdf:type schema:PublicationIssue
66 Nbb33db3abbf448caa1c97464b00f5202 rdf:first sg:person.013315250654.53
67 rdf:rest N157130a79d314fe295426b5fdf1c3155
68 Nbb4cb516c9854948905db0b755b66a9c schema:name doi
69 schema:value 10.1186/s12890-018-0775-5
70 rdf:type schema:PropertyValue
71 Nc01d9eeb6aa745bab2d8ac45749ba0d6 schema:name Springer Nature - SN SciGraph project
72 rdf:type schema:Organization
73 Nc174ca07a8b24048b38d7e3ead394b1a rdf:first sg:person.01143547471.25
74 rdf:rest Ne2992f34b7234dc88d66ab028bda0def
75 Ne1a37d88674048a3885e66d1943b9495 rdf:first sg:person.014312260733.08
76 rdf:rest Nc174ca07a8b24048b38d7e3ead394b1a
77 Ne2992f34b7234dc88d66ab028bda0def rdf:first sg:person.0671403157.95
78 rdf:rest Nfca42469383a4dc785836747b489b2eb
79 Nf3c8130ab2594ffe808cd6d7e0a6ace3 rdf:first sg:person.0742436717.71
80 rdf:rest rdf:nil
81 Nfca42469383a4dc785836747b489b2eb rdf:first sg:person.01371171317.49
82 rdf:rest Nf3c8130ab2594ffe808cd6d7e0a6ace3
83 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
84 schema:name Medical and Health Sciences
85 rdf:type schema:DefinedTerm
86 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
87 schema:name Oncology and Carcinogenesis
88 rdf:type schema:DefinedTerm
89 sg:journal.1024955 schema:issn 1471-2466
90 schema:name BMC Pulmonary Medicine
91 rdf:type schema:Periodical
92 sg:person.01061777002.04 schema:affiliation https://www.grid.ac/institutes/grid.411119.d
93 schema:familyName Brosseau
94 schema:givenName Solenn
95 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01061777002.04
96 rdf:type schema:Person
97 sg:person.01143547471.25 schema:affiliation https://www.grid.ac/institutes/grid.411119.d
98 schema:familyName Khalil
99 schema:givenName Antoine
100 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143547471.25
101 rdf:type schema:Person
102 sg:person.01265670501.55 schema:affiliation https://www.grid.ac/institutes/grid.411119.d
103 schema:familyName Danel
104 schema:givenName Claire
105 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265670501.55
106 rdf:type schema:Person
107 sg:person.013315250654.53 schema:affiliation https://www.grid.ac/institutes/grid.411119.d
108 schema:familyName Stelianides
109 schema:givenName Sandrine
110 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013315250654.53
111 rdf:type schema:Person
112 sg:person.013444441273.04 schema:affiliation https://www.grid.ac/institutes/grid.411119.d
113 schema:familyName Pluvy
114 schema:givenName Johan
115 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013444441273.04
116 rdf:type schema:Person
117 sg:person.01371171317.49 schema:affiliation https://www.grid.ac/institutes/grid.411119.d
118 schema:familyName Zalcman
119 schema:givenName Gérard
120 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01371171317.49
121 rdf:type schema:Person
122 sg:person.014312260733.08 schema:affiliation https://www.grid.ac/institutes/grid.411119.d
123 schema:familyName Nguenang
124 schema:givenName Marina
125 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014312260733.08
126 rdf:type schema:Person
127 sg:person.0671403157.95 schema:affiliation https://www.grid.ac/institutes/grid.411119.d
128 schema:familyName Crestani
129 schema:givenName Bruno
130 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0671403157.95
131 rdf:type schema:Person
132 sg:person.0742436717.71 schema:affiliation https://www.grid.ac/institutes/grid.411119.d
133 schema:familyName Gounant
134 schema:givenName Valérie
135 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0742436717.71
136 rdf:type schema:Person
137 https://doi.org/10.1016/j.anndiagpath.2015.06.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048936505
138 rdf:type schema:CreativeWork
139 https://doi.org/10.1056/nejmoa1100391 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002019704
140 rdf:type schema:CreativeWork
141 https://doi.org/10.1056/nejmoa1504627 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052572745
142 rdf:type schema:CreativeWork
143 https://doi.org/10.1056/nejmoa1507643 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000663586
144 rdf:type schema:CreativeWork
145 https://doi.org/10.1056/nejmoa1606774 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037631694
146 rdf:type schema:CreativeWork
147 https://doi.org/10.1056/nejmra1703481 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100292997
148 rdf:type schema:CreativeWork
149 https://doi.org/10.1164/rccm.200409-1298oc schema:sameAs https://app.dimensions.ai/details/publication/pub.1018349460
150 rdf:type schema:CreativeWork
151 https://doi.org/10.1164/rccm.201308-1483st schema:sameAs https://app.dimensions.ai/details/publication/pub.1032608484
152 rdf:type schema:CreativeWork
153 https://doi.org/10.1165/rcmb.2018-0123oc schema:sameAs https://app.dimensions.ai/details/publication/pub.1106103078
154 rdf:type schema:CreativeWork
155 https://doi.org/10.1183/13993003.00412-2015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022541062
156 rdf:type schema:CreativeWork
157 https://doi.org/10.1378/chest.07-0898 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033754583
158 rdf:type schema:CreativeWork
159 https://doi.org/10.2147/clep.s50780 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026267450
160 rdf:type schema:CreativeWork
161 https://doi.org/10.2353/ajpath.2009.090525 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045545118
162 rdf:type schema:CreativeWork
163 https://doi.org/10.2353/ajpath.2009.090900 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011644532
164 rdf:type schema:CreativeWork
165 https://doi.org/10.3322/caac.21262 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013257560
166 rdf:type schema:CreativeWork
167 https://www.grid.ac/institutes/grid.411119.d schema:alternateName Hôpital Bichat-Claude-Bernard
168 schema:name CIC INSERM 1425-CLIP2 Paris-Nord, Hôpital Bichat-Claude Bernard, 46 rue Henri Huchard 75018, AP-HP, Paris, France
169 Service de Pneumologie, Hôpital Bichat, 46 rue Henri Huchard, 75018, Paris, France
170 Service de Radiologie, Hôpital Bichat, 46 rue Henri Huchard, 75018, Paris, France
171 Service de Réhabilitation Respiratoire, Hôpital Bichat, 46 rue Henri Huchard, 75018, Paris, France
172 Service d’Anatomie Pathologique, Hôpital Bichat, 46 rue Henri Huchard, 75018, Paris, France
173 Service d’Oncologie Thoracique, Hôpital Bichat, 46 rue Henri Huchard, 75018, Paris, France
174 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...